Crystal structures of Burkholderia cenocepacia dihydropteroate synthase in the apo-form and complexed with the product 7,8-dihydropteroate

Morgan, Rachel E.; Batot, Gaëlle O.; Dement, Jennifer M.; Rao, Vincenzo A.; Eadsforth, Thomas C.; Hunter, William N.
January 2011
BMC Structural Biology;2011, Vol. 11 Issue 1, p21
Academic Journal
Background: The enzyme dihydropteroate synthase (DHPS) participates in the de novo synthesis of folate cofactors by catalyzing the formation of 7,8-dihydropteroate from condensation of p-aminobenzoic acid with 6-hydroxymethyl-7,8-dihydropteroate pyrophosphate. DHPS is absent from humans, who acquire folates from diet, and has been validated as an antimicrobial therapeutic target by chemical and genetic means. The bacterium Burkholderia cenocepacia is an opportunistic pathogen and an infective agent of cystic fibrosis patients. The organism is highly resistant to antibiotics and there is a recognized need for the identification of new drugs against Burkholderia and related Gram-negative pathogens. Our characterization of the DHPS active site and interactions with the enzyme product are designed to underpin early stage drug discovery. Results: An efficient recombinant protein expression system for DHPS from B. cenocepacia (BcDHPS) was prepared, the dimeric enzyme purified in high yield and crystallized. The structure of the apo-enzyme and the complex with the product 7,8-dihydropteroate have been determined to 2.35 Ã… and 1.95 Ã… resolution respectively in distinct orthorhombic crystal forms. The latter represents the first crystal structure of the DHPS-pterin product complex, reveals key interactions involved in ligand binding, and reinforces data generated by other structural studies. Comparisons with orthologues identify plasticity near the substrate-binding pocket and in particular a range of loop conformations that contribute to the architecture of the DHPS active site. These structural data provide a foundation for hit discovery. An intriguing observation, an artifact of the analysis, that of a potential sulfenamide bond within the ligand complex structure is mentioned. Conclusion: Structural similarities between BcDHPS and orthologues from other Gram-negative species are evident as expected on the basis of a high level of sequence identity. The presence of 7,8-dihydropteroate in the binding site provides details about ligand recognition by the enzyme and the different states of the enzyme allow us to visualize distinct conformational states of loops adjacent to the active site. Improved drugs to combat infections by Burkholderia sp. and related Gram-negative bacteria are sought and our study now provides templates to assist that process and allow us to discuss new ways of inhibiting DHPS.


Related Articles

  • Building an understanding of cystic fibrosis on the foundation of ABC transporter structures. Juan Mendoza; Philip Thomas // Journal of Bioenergetics & Biomembranes;Dec2007, Vol. 39 Issue 5/6, p499 

    Abstract  Cystic fibrosis (CF) is a fatal disease affecting the lungs and digestive system by impairment of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). While over 1000 mutations in CFTR have been associated with CF, the majority of cases are linked to the...

  • The Mutation Spectrum of the CFTR Gene in Cystic Fibrosis Patients from Bashkortostan. Korytina, G.F.; Viktorova, T.V.; Ivashchenko, T.E.; Baranov, V.S.; Khusnutdinova, E.K. // Molecular Biology;Jan/Feb2003, Vol. 37 Issue 1, p56 

    Mutations of CFTR were studied in patients with cystic fibrosis (CF) from Bashkortostan. In total, 15 mutations were observed and 51% of all mutant alleles identified. The most diagnostically significant mutations were delF508 (33.8%), 394delTT (3.52%), CFTRdele2,3(21kb) (1.41%), R334W (1.41%),...

  • Modeling the Conformational Changes Underlying Channel Opening in CFTR. Rahman, Kazi S.; Cui, Guiying; Harvey, Stephen C.; McCarty, Nael A. // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator protein (CFTR) cause cystic fibrosis (CF), the most common life-shortening genetic disease among Caucasians. Although general features of the structure of CFTR have been predicted from homology models, the...

  • Therapeutic approaches to cystic fibrosis: Memorandum from a joint WHO/ICF(M)A meeting.  // Bulletin of the World Health Organization;1994, Vol. 72 Issue 3, p341 

    Cystic fibrosis is one of the commonest genetic diseases among Caucasians and represents an important cause of suffering and death among children and adults. In the past two decades marked prolongation of the life of patients with cystic fibrosis has been achieved as the result of improved...

  • Novel Pharmaceutical Approaches for Treating Patients with Cystic Fibrosis. Saeed, Z.; Wojewodka, G.; Marion, D.; Guilbault, C.; Radzioch, D. // Current Pharmaceutical Design;Nov2007, Vol. 13 Issue 31, p3252 

    Before the cloning of the CFTR gene in 1989, there were relatively few treatment options for the many phenotypes associated with cystic fibrosis (CF). The advancement of research in areas such as immunology, molecular biology and pharmacology have provided new insights into the mechanism and...

  • A disease called 'sixty-five roses'.  // Nature Structural Biology;Dec2002, Vol. 9 Issue 12, p887 

    Provides information on cystic fibrosis (CF). Cause of CF; Increase in efforts to educate the public about preventing CF; Initial screen for CF.

  • CYSTIC FIBROSIS NO LONGER A FATAL DISEASE. Braverman, Jane // Exceptional Parent;Nov2001, Vol. 31 Issue 11, p87 

    Provides information on cystic fibrosis. Background on the disease; Life expectancies of patients; Diagnosis of the illness; Treatment of the disease.

  • Activation of the epithelial Na+ channel (ENaC) requires CFTR CI- channel function. Reddy; Light, M.M. // Nature;11/18/1999, Vol. 402 Issue 6759, p301 

    Examines the ion channel regulation in the genetic disease cystic fibrosis. Dependence of epithelial Na+ channel on CFTR activity; Primary defect in Cl- channel permeability in cystic fibrosis; Factors in the reduced salt absorption in cystic fibrosis.

  • Genetic Data on Cystic Fibrosis (Mucoviscidosis).  // Clinical Pediatrics;Jun1972, Vol. 11 Issue 6, p333 

    Presents an abstract of a study about genetic data on cystic fibrosis by R. Gilly, M. Hermier, J. M. Robert, M. J. Challamel and G. Gery.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics